{"disease":{"id":"clinical-trial-phase-i","name":"clinical trial phase i"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02817100","title":"First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03212586","title":"BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03210246","title":"Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03402438","title":"Renal Impairment Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04375267","title":"177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT03484585","title":"Rogaratinib (BAY1163877) Human Mass Balance Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Bayer","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}